Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Lefebvre

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Oral Oncology|July 25, 2006
A simple predictive model for postoperative mortality after head and neck cancer surgery with opening of mucosaNicolas Penel, Eric Yaovi Amela, Yann Mallet, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility studyBénédicte Comet, Andrew Kramar, Mathieu Faivre-Pierret, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2009
Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinomaFabienne Thomas, Philippe Rochaix, Melanie White-Koning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinomaFabienne Thomas, Philippe Rochaix, Adil Benlyazid, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2013
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancerEric F Lartigau, Emmanuelle Tresch, Juliette Thariat, et al.
Cancer|January 24, 2014
An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology GroupAndrew Bottomley, Gloria Tridello, Corneel Coens, et al.
Cancer Epidemiology|June 4, 2019
Prevalence and characteristics of HPV-driven oropharyngeal cancer in FranceHaitham Mirghani, Carine Bellera, Jessy Delaye, et al.
Head & Neck|September 29, 2007
Recent changes in the treatment of patients with advanced laryngeal cancerEric M Genden, Alfio Ferlito, Alessandra Rinaldo, et al.
The New England Journal of Medicine|October 26, 2007
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancerJan B Vermorken, Eva Remenar, Carla van Herpen, et al.
Head & Neck|October 22, 2005
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?Phillip K Pellitteri, Alfio Ferlito, Alessandra Rinaldo, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Oral Oncology|July 25, 2006
A simple predictive model for postoperative mortality after head and neck cancer surgery with opening of mucosaNicolas Penel, Eric Yaovi Amela, Yann Mallet, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility studyBénédicte Comet, Andrew Kramar, Mathieu Faivre-Pierret, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2009
Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinomaFabienne Thomas, Philippe Rochaix, Melanie White-Koning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinomaFabienne Thomas, Philippe Rochaix, Adil Benlyazid, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2013
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancerEric F Lartigau, Emmanuelle Tresch, Juliette Thariat, et al.
Cancer|January 24, 2014
An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology GroupAndrew Bottomley, Gloria Tridello, Corneel Coens, et al.
Cancer Epidemiology|June 4, 2019
Prevalence and characteristics of HPV-driven oropharyngeal cancer in FranceHaitham Mirghani, Carine Bellera, Jessy Delaye, et al.
Head & Neck|September 29, 2007
Recent changes in the treatment of patients with advanced laryngeal cancerEric M Genden, Alfio Ferlito, Alessandra Rinaldo, et al.
The New England Journal of Medicine|October 26, 2007
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancerJan B Vermorken, Eva Remenar, Carla van Herpen, et al.
Head & Neck|October 22, 2005
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?Phillip K Pellitteri, Alfio Ferlito, Alessandra Rinaldo, et al.
Pageof 6